Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marissa Lightbourne

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 17, 2024
Effects of Metreleptin in Patients With Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic DiseaseMaiah Brush, Sungyoung Auh, Elaine Cochran, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2026
Insulin Receptor Family Autoantibodies in Patients with Type B insulin ResistanceJennifer E Lee, Thilo S Chillon, Waldemar B Minich, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2023
Insulin Signaling Through the Insulin Receptor Increases Linear Growth Through Effects on Bone and the GH-IGF-1 AxisMarinna C Okawa, Rebecca M Tuska, Marissa Lightbourne, et al.
Journal of the Endocrine Society|August 18, 2021
Homozygous <i>SHBG</i> Variant (<i>rs6258</i>) Linked to Gonadotropin-Independent Precocious Puberty in a Young GirlVictoria C Andriessen, Marissa Lightbourne, Chelsi Flippo, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2019
Thyroid Abnormalities in Patients With Extreme Insulin Resistance SyndromesYevgeniya S Kushchayeva, Sergiy V Kushchayev, Megan Startzell, et al.
The Journal of Clinical Investigation|March 20, 2020
Free fatty acid processing diverges in human pathologic insulin resistance conditionsHilal Sekizkardes, Stephanie Therese Chung, Shaji Chacko, et al.
Journal of the Endocrine Society|January 14, 2021
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after MetreleptinMarissa Lightbourne, Anna Wolska, Brent S Abel, et al.
Journal of Clinical Lipidology|October 4, 2022
Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophyMarissa Lightbourne, Megan Startzell, Kimberley D Bruce, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Tirzepatide for LipodystrophyRasimcan Meral, Merve Celik Guler, Diarratou Kaba, et al.
Diabetes Care|March 10, 2025
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?Rasimcan Meral, Merve Celik Guler, Diarratou Kaba, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|May 17, 2024
Effects of Metreleptin in Patients With Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic DiseaseMaiah Brush, Sungyoung Auh, Elaine Cochran, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2026
Insulin Receptor Family Autoantibodies in Patients with Type B insulin ResistanceJennifer E Lee, Thilo S Chillon, Waldemar B Minich, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2023
Insulin Signaling Through the Insulin Receptor Increases Linear Growth Through Effects on Bone and the GH-IGF-1 AxisMarinna C Okawa, Rebecca M Tuska, Marissa Lightbourne, et al.
Journal of the Endocrine Society|August 18, 2021
Homozygous <i>SHBG</i> Variant (<i>rs6258</i>) Linked to Gonadotropin-Independent Precocious Puberty in a Young GirlVictoria C Andriessen, Marissa Lightbourne, Chelsi Flippo, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2019
Thyroid Abnormalities in Patients With Extreme Insulin Resistance SyndromesYevgeniya S Kushchayeva, Sergiy V Kushchayev, Megan Startzell, et al.
The Journal of Clinical Investigation|March 20, 2020
Free fatty acid processing diverges in human pathologic insulin resistance conditionsHilal Sekizkardes, Stephanie Therese Chung, Shaji Chacko, et al.
Journal of the Endocrine Society|January 14, 2021
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after MetreleptinMarissa Lightbourne, Anna Wolska, Brent S Abel, et al.
Journal of Clinical Lipidology|October 4, 2022
Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophyMarissa Lightbourne, Megan Startzell, Kimberley D Bruce, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Tirzepatide for LipodystrophyRasimcan Meral, Merve Celik Guler, Diarratou Kaba, et al.
Diabetes Care|March 10, 2025
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?Rasimcan Meral, Merve Celik Guler, Diarratou Kaba, et al.
Pageof 3